— Know what they know.
Not Investment Advice

PHIL.MI MIL

Philogen S.p.A.
1W: -1.8% 1M: -4.1% 3M: -9.8% YTD: +3.7% 1Y: -5.9% 3Y: +34.5%
€22.20 ($24.82)
-0.10 (-0.45%)
 
Weekly Expected Move ±3.5%
€21 €21 €22 €23 €24
MIL · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · €641.1M mcap · 11M float · 0.192% daily turnover

Income Trends

Revenue
$74M +219.9% ▲
5Y CAGR: +42.5%
Gross Profit
$54M +860.0% ▲
Operating Income
$38M +526.8% ▲
Net Income
$45M +835.1% ▲
5Y CAGR: +100.4%
EPS (Diluted)
$1.12 +846.7% ▲
5Y CAGR: +87.8%
EBITDA
$45M +2286.0% ▲
5Y CAGR: +63.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$5M$2M$24M$23M$74M
YoY Growth-62.1%-47.8%+850.0%-2.5%+219.9%
Cost of Revenue$10M$11M$13M$17M$20M
Gross Profit-$5M-$8M$11M$6M$54M
Gross Margin-105.8%-326.0%44.4%24.5%73.5%
R&D Expenses$12M$13M$16M$21M$0
SG&A Expenses-$8M-$10M-$12M-$16M$0
Operating Expenses$7M$9M$14M$15M$17M
Operating Income-$12M-$17M$240K-$9M$38M
Operating Margin-253.9%-672.1%1.0%-38.2%51.0%
Interest Expense$397K$403K$406K$547K$521K
Income Before Tax-$12M-$15M-$4M-$6M$40M
Tax Expense$866K$485K$1M-$20K-$5M
Net Income-$13M-$16M-$5M-$6M$45M
Net Margin-278.0%-630.0%-22.7%-26.6%61.2%
EPS (Diluted)$-0.45$-0.40$-0.13$-0.15$1.12
EBITDA-$11M-$13M-$1M-$2M$45M
Shares Outstanding29M40M40M40M40M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms